Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study

Brigitte Leininger-Muller, Aline Hoy, Bernard Herbeth, Michèle Pfister, Jean Marie Serot, Marina Stavljenic-Rukavina, Luis Massana, P Passmore, Gérard Siest, Sophie Visvikis

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)

Abstract

Alzheimer's disease (AD) is the most common cause of dementia in the elderly. Epidemiological and molecular genetic studies have shown the existence of several genes associated with increased risk of AD, the major genetic susceptibility locus coding for apolipoprotein E (apoE). A polymorphism in the myeloperoxidase gene (MPO) has previously been associated with AD susceptibility. However, results in the literature are controversial and seem to be dependent on several factors such as gender, apoE polymorphism or the genetic structure of the population. We investigated MPO G-463A and apoE polymorphism in 265 cases and 246 controls from the ApoEurope Study. In females, we found a significant association between MPO genotype and AD (P=0.034), GG genotype frequency being lower in cases (52.4%) as compared to controls (64.2%). In men, there was no significant effect of MPO polymorphism. No interaction was found between MPO polymorphism and apoE epsilon 4 allele. In conclusion, the G-463A polymorphism of MPO was statistically associated with AD in a gender-specific manner. However, given the low significance of P value we suggest no causal effect of the MPO gene in AD, as also evidenced in a recent meta-analysis. Our results support the hypothesis of a possible linkage disequilibrium between the MPO G-463A gene polymorphism and another functional variant involved in AD.
Original languageEnglish
Pages (from-to)95-98
Number of pages4
JournalNeuroscience Letters
Volume349
Issue number2
Publication statusPublished - 2003

Bibliographical note

Unrecognised author: 'for the ApoEurope Group'

Fingerprint Dive into the research topics of 'Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study'. Together they form a unique fingerprint.

Cite this